Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinical Trials Registration Bill From Democrats Includes Monetary Penalties

Executive Summary

A House and Senate bill mandating clinical trial registration uses institutional review board approval and civil monetary penalties to enforce compliance

You may also be interested in...



ClinicalTrials.gov Postings Should Include Studies For All Diseases – PhRMA

PhRMA member companies are committing to posting clinical study information on the ClinicalTrials.gov database for all diseases and conditions, not only for those that are "serious or life-threatening.

FDA Delays ClinicalTrials.gov Report To Include Additional Oncology Studies

FDA will include three additional months of oncology study listings in its report on the ClinicalTrials.gov registry

FDA Delays ClinicalTrials.gov Report To Include Additional Oncology Studies

FDA will include three additional months of oncology study listings in its report on the ClinicalTrials.gov registry

Related Content

UsernamePublicRestriction

Register

PS142970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel